Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Nobel for mRNA: Which other biotech stocks might be overlooked?
08:33am, Friday, 06'th Oct 2023
Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA v
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
08:27am, Friday, 06'th Oct 2023
With the current sector-wide downturn, it's not surprising that several large healthcare stocks are currently undervalued, relative to their intrinsic value, based on their fundamentals, cash flows, a
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
06:00am, Friday, 06'th Oct 2023
Moderna just reported positive data from its combined flu/coronavirus vaccine candidate and aims to launch a phase 3 trial. The potential product could appeal to people who already go for flu vaccines
Investing In Moderna: A Speculative Buy For Long-Term Gains
03:21pm, Thursday, 05'th Oct 2023
Moderna is a biotech company with high potential upside, despite the decline in demand for its COVID-19 vaccine. The company's mRNA platform approach has advantages over traditional vaccine manufactur
Moderna (MRNA) to Advance COVID/Flu Combo Jab to Late-Stage Study
12:02pm, Thursday, 05'th Oct 2023
Moderna's (MRNA) intends to start the late-stage study on its COVID-19-influenza combination vaccine candidate before year-end. A commercial launch is expected in 2025.
Moderna reportedly files submission for RSV vaccine with Health Canada
11:41am, Thursday, 05'th Oct 2023
Moderna Therapeutics Inc (NASDAQ:MRNA) has filed a new drug submission for its vaccine aimed at preventing respiratory syncytial virus (RSV) in adults aged 60 and older with Health Canada, according t
Can Moderna Achieve Its Most Ambitious Goal Yet?
05:30am, Thursday, 05'th Oct 2023
Investors have worried about Moderna's post-pandemic earnings since the company relies on its coronavirus vaccine for revenue. Moderna has been progressing toward its goal of becoming a multiproduct c
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
07:33pm, Wednesday, 04'th Oct 2023
In the latest trading session, Moderna (MRNA) closed at $104.26, marking a +1.14% move from the previous day.
Moderna CEO on combo Covid, flu vaccine moving to next trial phase
12:55pm, Wednesday, 04'th Oct 2023
A lot of Americans are planning on getting both a flu shot and Covid booster this fall. But Moderna (MRNA) has been working on a combination flu and Covid vaccine, so patients only need to get one sho
Moderna reports positive results for combination flu and COVID vaccine
08:09am, Wednesday, 04'th Oct 2023
Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday, and said it would start a Phase 3 trial for adults aged 50 and
Moderna combo COVID-19/flu vaccine succeeds in early-stage trial
07:07am, Wednesday, 04'th Oct 2023
Moderna on Wednesday said its combination vaccine to protect against both COVID-19 and influenza generated a strong immune response compared to individual shots for the viruses in an early-stage study
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
07:00am, Wednesday, 04'th Oct 2023
Moderna and other vaccine makers like Pfizer believe combination shots will simplify what people can do to protect themselves against Covid, RSV and the flu.
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
04:36pm, Tuesday, 03'rd Oct 2023
The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.
02:44pm, Tuesday, 03'rd Oct 2023
Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
10:07pm, Sunday, 01'st Oct 2023
These three companies have a proven ability to develop innovative products in the healthcare field. All three have performed poorly on the market over the past year, but their prospects remain intact.
